{"id":1669,"date":"2023-06-25T17:29:32","date_gmt":"2023-06-25T17:29:32","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/betamethasone\/"},"modified":"2023-06-25T19:49:54","modified_gmt":"2023-06-25T19:49:54","slug":"betamethasone","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/betamethasone\/","title":{"rendered":"Betamethasone"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kidneydiseaseclinic.net\/renaldrugs\/img\/Betamethasone.JPG\"><\/p>\n<h1>Betamethasone<\/h1>\n<h3>  CLINICAL USE<\/h3>\n<p>Corticosteroid:<\/p>\n<li>Suppression of inflammatory and allergic  disorders<\/li>\n<li>Congenital adrenal hyperplasia<br \/>\n<h3> DOSE IN NORMAL RENAL FUNCTION<\/h3>\n<p>Oral: 0.5\u20135 mg dailyInjection: 4\u201320 mg repeated up to 4 times in 24 hours<\/p>\n<h3>  PHARMACOKINETICS<\/h3>\n<\/li>\n<li> Molecular weight &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :392.5<\/li>\n<li>  %Protein binding  &nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :65<\/li>\n<li>  %Excreted unchanged in urine &nbsp; &nbsp; : 5<\/li>\n<li> Volume of distribution (L\/kg) &nbsp; &nbsp; &nbsp; :1.4<\/li>\n<li>half-life \u2013 normal\/ESRD (hrs)&nbsp; &nbsp; &nbsp; :5.5\/\u2013<br \/>\n<h3>  DOSE IN RENAL IMPAIRMENT<\/h3>\n<h4>GFR (mL\/MIN)<\/h4>\n<\/li>\n<li> 20 to 50  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> 10 to 20  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> &lt;10 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : Dose as in normal renal function<br \/>\n<h3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES<\/h3>\n<\/li>\n<li> CAPD  &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;:Unknown dialysability. Dose as in normal renal function<\/li>\n<li> HD &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; :Unknown dialysability. Dose as in normal renal function<\/li>\n<li>HDF\/high flux  &nbsp; :Unknown dialysability. Dose as in normal renal function<\/li>\n<li>CAV\/VVHD  &nbsp; &nbsp; &nbsp;:Unknown dialysability. Dose as in normal renal function<br \/>\n<h3> IMPORTANT DRUG INTERACTIONS<\/h3>\n<p>Potentially hazardous interactions with other drugs<\/li>\n<li>Antibacterials: metabolism accelerated by  rifampicin; metabolism possibly inhibited by erythromycin<\/li>\n<li>Anticoagulants: efficacy of coumarins may  be altered<\/li>\n<li>Anti-epileptics: metabolism accelerated by  carbamazepine, barbiturates, phenytoin and primidoneAntifungals: increased risk of  hypokalaemia with amphotericin \u2013 avoid concomitant use; metabolism possibly inhibited by itraconazole and ketoconazoleA<\/li>\n<li>ntivirals: concentration possibly  increased by ritonavir<\/li>\n<li>Ciclosporin: rare reports of convulsions  in patients on ciclosporin and high-dose corticosteroids<\/li>\n<li>Cytotoxics: increased risk of  haematological toxicity with methotrexate<\/li>\n<li>Diuretics: enhanced hypokalaemic effects  of acetazolamide, loop diuretics and thiazide diuretics<\/li>\n<li>Vaccines: high-dose corticosteroids can  impair immune response to vaccines; avoid concomitant use with live vaccines<br \/>\n<h3> ADMINISTRATION<\/h3>\n<h4> Reconstition<\/h4>\n<p>\u2013<\/p>\n<h4>  Route<\/h4>\n<p>Orally, IV, IM, topically<\/p>\n<h4>  Rate of Administration<\/h4>\n<p>IV bolus: over half to one minute<\/p>\n<h4>Comments<\/h4>\n<p>Can be added to glucose 5% or sodium  chloride 0.9%<\/p>\n<h4>  OTHER INFORMATION<\/h4>\n<\/li>\n<li>750 micrograms betamethasone  \u2261 5 mg prednisolone<\/li>\n<li>Even when applied topically, sufficient  corticosteroid may be absorbed to give a systemic effec<\/li>\n<li>tEffects of betamethasone on sodium and  water retention are less than those of prednisolone and approximately equal to those of dexamethasone<\/li>\n","protected":false},"excerpt":{"rendered":"<p>Betamethasone CLINICAL USE Corticosteroid: Suppression of inflammatory and allergic disorders<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-1669","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=1669"}],"version-history":[{"count":1,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1669\/revisions"}],"predecessor-version":[{"id":2889,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/1669\/revisions\/2889"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=1669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=1669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=1669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}